Tools

LEADER 03529nam a2200553 i 4500

001 on1409349005;

003 OCoLC;

005 20240122153612.0;

006 m o d f ;

007 cr |||||||||||;

008 231114s2023 dcua ob f000 0 eng c;

024 8 a| 48-906q| (GPO jacket number);

035 a| (Sirsi) o1409349005;

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

074 a| 1043-C (online);

086 0 a| Y 4.L 11/4:S.HRG.117-395;

245 10 a| FDA user fee agreements: advancing medical product regulation and innovation for the benefit of patients, FDA center directors :b| hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventeenth Congress, second session on examining Food and Drug Administration user fee agreements, focusing on advancing medical product regulation and innovation for the benefit of patients and Food and Drug Administration center directors, April 26, 2022.;

264 1 a| Washington :b| U.S. Government Publishing Office,c| 2023.;

300 a| 1 online resource (iii, 106 pages) :b| color illustrations.;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

490 1 a| S. hrg. ;v| 117-395;

500 a| Access ID (govinfo): CHRG-117shrg48906.;

500 a| Associated bill citation(s): S. 4071.;

500 a| In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).;

500 a| GPO Cataloging Record Distribution Program (CRDP).;

504 a| Includes bibliographical references.;

511 0 a| Hearing witnesses: Cavazzoni, Patrizia, M.D., Director, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD; Marks, Peter, M.D., Ph.D., Director, Center for Biologics Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD; Shuren, Jeffrey, M.D., J.D., Director, Center for Devices and Radiological Health, United States Food and Drug Administration, Silver Spring, MD.;

518 a| Date of hearing: 2022-04-26.;

588 a| Description based on online resource; title from PDF title page (GovInfo, viewed November 14, 2023).;

650 0 a| User chargesz| United States.=| ^A420592;

650 0 a| Drug approvalz| United States.=| ^A1001108;

650 0 a| Medical suppliesx| Certificationz| United States.=| ^A450443;

655 7 a| Legislative hearings.2| lcgft0| https://id.loc.gov/authorities/genreForms/gf2013025047;

776 08 i| Print version:a| United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.t| FDA user fee agreements: advancing medical product regulation and innovation for the benefit of patients, FDA center directorsw| (OCoLC)1409349004;

856 40 u| https://purl.fdlp.gov/GPO/gpo2202137| 0;

922 a| BIBCONEWb| 20231114;

922 a| GOVINFOHRG;

922 a| PUBPOLTERMS;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 6282343;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 6282343-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 12/11/2023x| EDOCUMENTz| JERESOURCE;

FDA user fee agreements: advancing medical product regulation and innovation for the benefit of patients, FDA center directors : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventeenth Congress, second session on examining Food and Drug Administration user fee agreements, focusing on advancing medical product regulation and innovation for the benefit of patients and Food and Drug Administration center directors, April 26, 2022.

Author/creator	United States
Format	Electronic
Publication	Washington : U.S. Government Publishing Office, 2023.
Description	1 online resource (iii, 106 pages) : color illustrations.
Supplemental Content	https://purl.fdlp.gov/GPO/gpo220213
Subjects	User charges--United States. Drug approval--United States. Medical supplies--Certification. --United States.

Series	S. hrg. ; 117-395 United States. Congress. Senate. S. hrg. ; https://id.loc.gov/authorities/names/n83707917 ; 117-395. ^A500722
General note	Access ID (govinfo): CHRG-117shrg48906.
General note	Associated bill citation(s): S. 4071.
General note	In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).
General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Includes bibliographical references.
Performer	Hearing witnesses: Cavazzoni, Patrizia, M.D., Director, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD; Marks, Peter, M.D., Ph.D., Director, Center for Biologics Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD; Shuren, Jeffrey, M.D., J.D., Director, Center for Devices and Radiological Health, United States Food and Drug Administration, Silver Spring, MD.
Date/time/place of a event note	Date of hearing: 2022-04-26.
Source of description	Description based on online resource; title from PDF title page (GovInfo, viewed November 14, 2023).
Issued in other form	Print version: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. FDA user fee agreements: advancing medical product regulation and innovation for the benefit of patients, FDA center directors
Genre/form	Legislative hearings.
Standard identifier#	48-906 (GPO jacket number)
GPO item number	1043-C (online)
Govt. docs number	Y 4.L 11/4:S.HRG.117-395

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Click here for more information about this title

Availability